SEARCH

SEARCH BY CITATION

References

  • Alp NJ, Channon KM (2004). Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24: 413420.
  • Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney Jr JF (2004). Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 279: 4663746643.
  • Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E et al. (2002). Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105: 576582.
  • Brownlee M (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813820.
  • Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ et al. (2004). Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24: 12661271.
  • Cai H, Harrison DG (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840844.
  • Cassini AF, Ferrali M, Pompella A, Maellaro E, Comporti M (1986). Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene-intoxicated mice. Am J Pathol 123: 520531.
  • Cayatte AJ, Rupin A, Oliver-Krasinski J, Maitland K, Sansilvestri-Morel P, Boussard MF et al. (2001). S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler Thromb Vasc Biol 21: 15771584.
  • Chang JW, Lee EK, Kim TH, Min WK, Chun S, Lee KU et al. (2007). Effects of α-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease failure on hemodialysis: a pilot study. Am J Nephrol 27: 7074.
  • Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H et al. (2001). Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto–Kakizaki rats. Hypertension 37: 433439.
  • Creager MA, Luscher TF, Cosentino F, Beckman JA (2003). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Circulation 108: 15271532.
  • Da Ros R, Assaloni R, Ceriello A (2005). Molecular targets of diabetic vascular complications and potential new drugs. Curr Drug Targets 6: 503509.
  • Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003). Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 2338.
  • de Roos NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB (2002). Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur J Clin Nutr 56: 674679.
  • de Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM (2000). Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963974.
  • Del Rio D, Stewart AJ, Pellegrini N (2005). A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15: 316328.
  • Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108: 13411348.
  • Goldberg IJ (2001). Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86: 965971.
  • Goldberg IJ, Dansky HM (2006). Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol 26: 16931701.
  • Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA et al. (2002). Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40: 946953.
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982). Analysis of nitrate, nitrite and 15[N] nitrate in biological fluids. Anal Biochem 126: 131138.
  • Gryglewski RJ, Palmer RM, Moncada S (1986). Superoxide anion is involved in the breakdown of endothelium derived vascular relaxing factor. Nature 320: 454456.
  • Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M et al. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14E22.
  • Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE (2007). Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques Circ Res 100: 769781.
  • Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS et al. (2004). Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10: 727733.
  • Kobayashi T, Taguchi K, Yasuhiro T, Matsumoto T, Kamata K (2004). Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 44: 956962.
  • Kocak G, Aktan F, Canbolat O, Ozogul C, Elberg S, Yildizoglu-Ari N et al. (2000). alpha-Lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13: 308318.
  • Lee WJ, Lee IK, Kim HS, Kim YM, Koh EH, Won JC et al. (2005). alpha-Lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol 25: 24882494.
  • Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186: 464478.
  • Lichtenstein AH, Matthan NR, Jalbert SM, Resteghini NA, Schaefer EJ, Ausman LM (2006). Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr 84: 497504.
  • Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL (1998). Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 12981305.
  • Molnar J, Yu S, Mzhavia N, Pau C, Chereshnev I, Dansky HM (2005). Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 96: 11781184.
  • Muller C, Dunschede F, Koch E, Vollmar AM, Kiemer AK (2003). alpha-Lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol 285: G769G778.
  • Murakami H, Murakami R, Kambe F, Cao X, Takahashi R, Asai T et al. (2006). Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC. Biochem Biophys Res Commun 341: 973978.
  • Nagareddy PR, Xia Z, McNeill J, MacLeod KM (2005). Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol 289: H2144H2152.
  • Packer L, Kraemer K, Rimbach G (2001). Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888895.
  • Payne JA, Reckelhoff JF, Khalil RA (2003). Role of oxidative stress in age-related reduction of NO-cGMP-mediated vascular relaxation in SHR. Am J Physiol 285: R542R551.
  • Reis ED, Roque M, Dansky H, Fallon JT, Badimon JJ, Cordon-Cardo C et al. (2000). Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 97: 1276412769.
  • Santos MS, Santos DL, Palmeira CM, Seica R, Moreno AJ, Oliveira CR (2001). Brain and liver mitochondria isolated from diabetic Goto–Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab Res Rev 17: 223230.
  • Schalkwijk CG, Stehouwer CD (2005). Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 109: 143159.
  • Seiça R, Suzuki K, Santos RM, Rosário LM (2004). Deficiência primária da secreção de insulina de ilhéus isolados de ratos Goto–Kakizaki, um modelo animal de diabetes tipo 2 não obesa. Acta Med Port 17: 4248.
  • Song KH, Lee WJ, Koh JM, Kim HS, Youn JY, Park HS et al. (2005). alpha-Lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. Biochem Biophys Res Commun 326: 197202.
  • Vasdev S, Gill V, Parai S, Gadag V (2005). Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem 275: 135141.
  • Visioli F, Smith A, Zhang W, Keaney Jr JF, Hagen T, Frei B (2002). Lipoic acid and vitamin C potentiate nitric oxide synthesis in human aortic endothelial cells independently of cellular glutathione status. Redox Rep 7: 223227.
  • Williams JM, Pearce WJ (2006). Age-dependent modulation of endothelium-dependent vasodilation by chronic hypoxia in ovine cranial arteries. J Appl Physiol 100: 225232.
  • Yi X, Maeda N (2006). Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apoliprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 55: 22382244.
  • Ziegler D, Gries FA (1997). alpha-Lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46: S62S66.
  • Zou MH, Shi C, Cohen RA (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817826.